↓ Skip to main content

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

Overview of attention for article published in Applied Health Economics and Health Policy, November 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
73 Mendeley
Title
Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany
Published in
Applied Health Economics and Health Policy, November 2019
DOI 10.1007/s40258-019-00523-1
Pubmed ID
Authors

Afschin Gandjour, Dennis A. Ostwald

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 18%
Student > Master 11 15%
Researcher 10 14%
Student > Ph. D. Student 4 5%
Student > Doctoral Student 3 4%
Other 10 14%
Unknown 22 30%
Readers by discipline Count As %
Medicine and Dentistry 22 30%
Pharmacology, Toxicology and Pharmaceutical Science 9 12%
Nursing and Health Professions 5 7%
Business, Management and Accounting 2 3%
Veterinary Science and Veterinary Medicine 2 3%
Other 9 12%
Unknown 24 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 November 2019.
All research outputs
#15,586,847
of 23,172,045 outputs
Outputs from Applied Health Economics and Health Policy
#557
of 788 outputs
Outputs of similar age
#226,502
of 366,254 outputs
Outputs of similar age from Applied Health Economics and Health Policy
#13
of 22 outputs
Altmetric has tracked 23,172,045 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 788 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.0. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,254 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.